Showing 11,901 - 11,920 results of 49,729 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((point decrease) OR (mean decrease)) ))', query time: 1.07s Refine Results
  1. 11901
  2. 11902
  3. 11903
  4. 11904
  5. 11905
  6. 11906
  7. 11907
  8. 11908
  9. 11909
  10. 11910

    Suitability of Porcine Chondrocyte Micromass Culture To Model Osteoarthritis in Vitro by Niels Schlichting (1783198)

    Published 2014
    “…Expression of genes related to cartilage ECM formation (<i>COL2A1</i>, <i>COL9A1</i>, <i>COMP</i>, <i>aggrecan</i>) as well as hypertrophic bone formation (<i>COL1A1</i>, <i>COL10A1</i>) was predominantly found decreased. …”
  11. 11911

    Suitability of Porcine Chondrocyte Micromass Culture To Model Osteoarthritis in Vitro by Niels Schlichting (1783198)

    Published 2014
    “…Expression of genes related to cartilage ECM formation (<i>COL2A1</i>, <i>COL9A1</i>, <i>COMP</i>, <i>aggrecan</i>) as well as hypertrophic bone formation (<i>COL1A1</i>, <i>COL10A1</i>) was predominantly found decreased. …”
  12. 11912

    Suitability of Porcine Chondrocyte Micromass Culture To Model Osteoarthritis in Vitro by Niels Schlichting (1783198)

    Published 2014
    “…Expression of genes related to cartilage ECM formation (<i>COL2A1</i>, <i>COL9A1</i>, <i>COMP</i>, <i>aggrecan</i>) as well as hypertrophic bone formation (<i>COL1A1</i>, <i>COL10A1</i>) was predominantly found decreased. …”
  13. 11913

    Suitability of Porcine Chondrocyte Micromass Culture To Model Osteoarthritis in Vitro by Niels Schlichting (1783198)

    Published 2014
    “…Expression of genes related to cartilage ECM formation (<i>COL2A1</i>, <i>COL9A1</i>, <i>COMP</i>, <i>aggrecan</i>) as well as hypertrophic bone formation (<i>COL1A1</i>, <i>COL10A1</i>) was predominantly found decreased. …”
  14. 11914
  15. 11915
  16. 11916
  17. 11917
  18. 11918
  19. 11919
  20. 11920

    Table 1_Trends and forecasts of vitamin A deficiency burden in China, 1990–2035.docx by Zhongming Ye (21865547)

    Published 2025
    “…However, DALYs rebounded among those aged 50–74 years. Significant age and sex disparities exist. …”